Programs, populations, and payments verified via SAMHSA.
- Level of care
- Outpatient · MAT · Telehealth
- Service settings
- Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
- Therapy approaches
- Brief intervention, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy, Trauma-related counseling
- Age groups
- Children/Adolescents, Adults
- Special populations
- Young adults, Adult women, Adult men, Criminal justice (other than DUI/DWI)/Forensic clients
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medications for HIV treatment, Medications for Hepatitis C treatment + 5 more
- Recovery supports
- Housing services, Assistance with obtaining social services, Mentoring/peer support
- Facility operation
- Local, county, or community government